UFP Technologies, Inc. Gain (Loss) Related to Litigation Settlement
UFP Technologies, Inc. (UFPT) reported Gain (Loss) Related to Litigation Settlement of $104.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2019-11-08
- UFP Technologies, Inc. gain (loss) related to litigation settlement for the quarter ending 2018-12-31 was $0.00.
- UFP Technologies, Inc. gain (loss) related to litigation settlement for the quarter ending 2018-09-30 was $0.00.
- UFP Technologies, Inc. gain (loss) related to litigation settlement for the quarter ending 2018-06-30 was $104.00K, a 14.05% decline year-over-year.
- UFP Technologies, Inc. gain (loss) related to litigation settlement for the quarter ending 2017-12-31 was $0.00.
- UFP Technologies, Inc. gain (loss) related to litigation settlement for fiscal 2018 was $104.00K, a 14.05% decline from fiscal 2017.
- UFP Technologies, Inc. gain (loss) related to litigation settlement for fiscal 2017 was $121.00K, a 94.28% decline from fiscal 2016.
- UFP Technologies, Inc. gain (loss) related to litigation settlement for fiscal 2016 was $2.11M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $104.00K derived: sum of 3 quarters · filed 2019-11-08 | $104.00K 10-K · filed 2019-03-15 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $104.00K derived: sum of 2 quarters · filed 2019-11-08 | $104.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $104.00K 10-Q · filed 2019-08-09 | $104.00K 10-Q · filed 2019-08-09 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $121.00K derived: sum of 3 quarters · filed 2019-03-15 | $121.00K 10-K · filed 2019-03-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $121.00K derived: sum of 2 quarters · filed 2018-11-09 | $121.00K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $121.00K 10-Q · filed 2018-08-09 | $121.00K 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $1.68M derived: sum of 2 quarters · filed 2019-03-15 | $2.11M derived: sum of 3 quarters · filed 2019-03-15 | $2.11M 10-K · filed 2019-03-15 |
| 2016-09-30 | $1.68M 10-Q · filed 2017-11-09 | $2.11M derived: sum of 2 quarters · filed 2017-11-09 | $2.11M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $432.00K 10-Q · filed 2017-08-09 | $432.00K 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |